Literature DB >> 26832760

Effect of detrusor botulinum toxin a injection on urothelial dysfunction in patients with chronic spinal cord injury: a clinical and immunohistochemistry study before and after treatment.

S-F Chen1, C-H Chang1, H-C Kuo1.   

Abstract

OBJECTIVE: The objective of this study is to investigate the changes of urothelial junction proteins, apoptosis and suburothelial inflammation after detrusor injection of botulinum toxin A (BoNT-A) in patients with spinal cord injury (SCI) and neurogenic detrusor overactivity (NDO).
METHODS: A total of 26 patients with chronic suprasacral SCI and NDO were enroled. The urothelium was assessed by cystoscopic biopsy at baseline, 3 and 6 months after a single treatment of 300 U BoNT-A into the detrusor. Immunofluorescence staining of E-cadherin, zonula occludens-1 (ZO-1) and tryptase for mast cell activity were performed. Urothelial apoptosis was also evaluated. The differences in urothelial dysfunction were compared between baseline and 3 and 6 months after treatment. Bladder biopsies from patients undergoing anti-incontinence surgery served as controls.
RESULTS: A single 300-U BoNT-A injection into the detrusor significantly decreased detrusor pressure and increased bladder compliance at 3 and 6 months after treatment. Significantly lower E-cadherin and ZO-1 expressions and increased mast cell and apoptotic cell counts were noted in SCI bladders compared with controls (all P<0.001). Significantly greater distributions of E-cadherin (P<0.001) and ZO-1 (P=0.05) expressions were noted 3 months after BoNT-A injection. However, these changes had declined by 6 months after treatment. Activated mast cells and urothelial apoptosis showed no significant differences between baseline and 3 or 6 months.
CONCLUSION: Urothelial dysfunction and adhesive and junction protein concentrations in SCI patients' bladders recovered after BoNT-A treatment. However, this effect decreased with time. Thus, neurogenic inflammation after SCI was not adequately improved after a single BoNT-A injection.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26832760     DOI: 10.1038/sc.2015.241

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  41 in total

1.  Techniques of image analysis for quantitative immunohistochemistry.

Authors:  E Kaczmarek; A Górna; P Majewski
Journal:  Rocz Akad Med Bialymst       Date:  2004

Review 2.  Epidemiology, demographics, and pathophysiology of acute spinal cord injury.

Authors:  L H Sekhon; M G Fehlings
Journal:  Spine (Phila Pa 1976)       Date:  2001-12-15       Impact factor: 3.468

3.  Videourodynamic characteristics and lower urinary tract symptoms of female bladder outlet obstruction.

Authors:  Hann-Chorng Kuo
Journal:  Urology       Date:  2005-11       Impact factor: 2.649

4.  Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity.

Authors:  David Ginsberg; Angelo Gousse; Veronique Keppenne; Karl-Dietrich Sievert; Catherine Thompson; Wayne Lam; Mitchell F Brin; Brenda Jenkins; Cornelia Haag-Molkenteller
Journal:  J Urol       Date:  2012-04-12       Impact factor: 7.450

5.  Higher levels of cell apoptosis and abnormal E-cadherin expression in the urothelium are associated with inflammation in patients with interstitial cystitis/painful bladder syndrome.

Authors:  Jia-Heng Shie; Hann-Chorng Kuo
Journal:  BJU Int       Date:  2010-12-16       Impact factor: 5.588

6.  OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivity.

Authors:  Eric Rovner; Roger Dmochowski; Christopher Chapple; Catherine Thompson; Wayne Lam; Cornelia Haag-Molkenteller
Journal:  Neurourol Urodyn       Date:  2013-02-06       Impact factor: 2.696

7.  Alterations in connexin expression in the bladder of patients with urge symptoms.

Authors:  Jochen Neuhaus; Friederike Pfeiffer; Hartwig Wolburg; Lars-Christian Horn; Wolfgang Dorschner
Journal:  BJU Int       Date:  2005-09       Impact factor: 5.588

8.  Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury.

Authors:  Mohit Khera; George T Somogyi; Susanna Kiss; Timothy B Boone; Christopher P Smith
Journal:  Neurochem Int       Date:  2004-12       Impact factor: 3.921

9.  Onabotulinumtoxin-A intradetrusorial injections modulate bladder expression of NGF, TrkA, p75 and TRPV1 in patients with detrusor overactivity.

Authors:  Antonella Giannantoni; Antonella Conte; Valerio Farfariello; Silvia Proietti; Alberto Vianello; Vincenza Nardicchi; Giorgio Santoni; Consuelo Amantini
Journal:  Pharmacol Res       Date:  2012-12-13       Impact factor: 7.658

10.  OnabotulinumtoxinA significantly attenuates bladder afferent nerve firing and inhibits ATP release from the urothelium.

Authors:  Valerie M Collins; Donna M Daly; Marina Liaskos; Neil G McKay; Donna Sellers; Christopher Chapple; David Grundy
Journal:  BJU Int       Date:  2013-08-13       Impact factor: 5.588

View more
  5 in total

1.  Urothelial proliferation and regeneration after spinal cord injury.

Authors:  F Aura Kullmann; Dennis R Clayton; Wily G Ruiz; Amanda Wolf-Johnston; Christian Gauthier; Anthony Kanai; Lori A Birder; Gerard Apodaca
Journal:  Am J Physiol Renal Physiol       Date:  2017-03-22

Review 2.  Complications of Botox and their Management.

Authors:  Rose Leu; Gillian L Stearns
Journal:  Curr Urol Rep       Date:  2018-09-07       Impact factor: 3.092

3.  Clinical Efficacy and Changes of Urothelial Dysfunction after Repeated Detrusor Botulinum Toxin A Injections in Chronic Spinal Cord-Injured Bladder.

Authors:  Sheng-Fu Chen; Chia-Hwei Chang; Hann-Chorng Kuo
Journal:  Toxins (Basel)       Date:  2016-05-30       Impact factor: 4.546

4.  Asiatic Acid, a Natural Compound that Exerts Beneficial Effects on the Cystometric and Biochemical Parameters in the Retinyl Acetate-Induced Model of Detrusor Overactivity.

Authors:  Andrzej Wróbel; Anna Serefko; Aleksandra Szopa; Ewa Poleszak
Journal:  Front Pharmacol       Date:  2021-01-29       Impact factor: 5.810

Review 5.  Will repeated botulinum toxin A improve detrusor overactivity and bladder compliance in patients with chronic spinal cord injury?

Authors:  Sheng-Fu Chen; Hann-Chorng Kuo
Journal:  Tzu Chi Med J       Date:  2020-07-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.